Literature DB >> 973995

Salivary antipyrine half-life: a useful measure of hepatic drug metabolism.

P M Brooks, M A Bell, H Burns.   

Abstract

Mesh:

Substances:

Year:  1976        PMID: 973995      PMCID: PMC1428950          DOI: 10.1111/j.1365-2125.1976.tb00656.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

1.  Relationship between digoxin concentrations in serum and saliva.

Authors:  D H Huffman
Journal:  Clin Pharmacol Ther       Date:  1975-03       Impact factor: 6.875

2.  Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.

Authors:  E S Vesell; G T Passananti; P A Glenwright; B H Dvorchik
Journal:  Clin Pharmacol Ther       Date:  1975-09       Impact factor: 6.875

3.  Assessment of plasma glutamyl transpeptidase activity and urinary D-glucaric acid excretion as indices of enzyme induction.

Authors:  D C Davidson; W B McIntosh; J A Ford
Journal:  Clin Sci Mol Med       Date:  1974-09
  3 in total
  4 in total

1.  Pharmacokinetics of antipyrine in epileptic patients.

Authors:  E M Rimmer; P A Routledge; L M Tsanaclis; A Richens
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

Review 2.  Oral absorption and secretion of drugs.

Authors:  C F Speirs
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

Review 3.  Clinical implications of enzyme induction and enzyme inhibition.

Authors:  B K Park; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

4.  Comparison of medigoxin and digoxin in the control of atrial fibrillation.

Authors:  P Coburn; G M Kongola; G E Mawer
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.